EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Time Trends in Cause-specific Mortality in Patients with Pulmonary Embolism Aged 50 Years and Older

Katarina Glise Sandblad iD, Kristina Svennerholm, Jacob Philipson, Maria Roupe, Aldina Pivodic, Andrea Dahl Sturedahl, Carl Johan Svensson, Sam Schulman iD, Mazdak Tavoly

Thrombosis and Haemostasis · 01.06.2026 · 126 (06) · 595-609

DOI: 10.1055/a-2668-5296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.06.2026. Verfasst von Katarina Glise Sandblad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Pulmonary Embolism, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Heart and Lung Foundation, Gothenburg Society of Medicine, Elsa and Gustav Lindh's Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with pulmonary embolism (PE) have high mortality rates. However, data on cause-specific mortality trends in this population are limited. To study time trends in cause-specific mortality among PE patients aged ≥50 years, analyzed across three time periods: 2006–2011, 2012–2017, and 2018–2023. The secondary aims included examining mortality trends in matched controls and subgroups of PE patients. This nationwide Swedish register study included patients with a first-time PE and matched controls. We assessed 30-day and 31- to 365-day cause-specific mortality and employed age- and sex-adjusted Poisson regression for the relative risk (RR) for annual mortality trends. The study comprised 115,476 patients, with cancer as the leading cause of 30-day mortality, stable at 4.7% from 2006–2011 to 2018–2023 (RR 1.00; 95% confidence interval [CI]: 0.99–1.01). Mortality from fatal venous thromboembolism (VTE) decreased from 2.7 to 1.3% (RR 0.94; 95% CI: 0.93–0.95), and cardiovascular disease from 2.3 to 1.1% (RR 0.94; 95% CI: 0.93–0.94). The 31- to 365-day mortality from cancer was stable at 11.8% in 2006–2011 and 11.4% in 2018–2022 (RR 1.00; 95% CI: 0.99–1.00), while mortality due to cardiovascular disease decreased from 4.1 to 2.3% (RR 0.96; CI: 0.95–0.96), and fatal VTE from 0.8 to 0.5% (RR 0.95; 95%: 0.93–0.96). Subgroup analysis showed a decrease in cancer-related mortality among PE patients with known cancer, while it increased in those without known cancer. Cancer was the leading cause of death in PE patients aged ≥50 years, with stable rates over time due to contrasting trends in patients with and without known cancer. Fatal VTE comprised a minor percentage of overall mortality in recent years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismNeoplasmsHumansMiddle AgedFemaleAgedMaleSwedenCause of DeathRegistriesTime FactorsAged, 80 and overRisk FactorsVenous ThromboembolismAge FactorsCardiovascular Diseases

Autor:innen und Institutionen

  • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Medicine, Geriatrics and Emergency Medicine, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.
  • Department of Anaesthesiology and Intensive Care, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Anaesthesiology and Intensive Care, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Medicine, Region Västra Götaland, Sahlgrenska University Hospital/Mölndal, Gothenburg, Sweden.
  • APNC Sweden, Gothenburg, Sweden.

ORCID-Profile: Katarina Glise Sandblad, Sam Schulman

Förderung

  • Swedish Heart and Lung Foundation
  • Gothenburg Society of Medicine
  • Elsa and Gustav Lindh's Foundation

Zitieren

APA

Glise Sandblad, K., Svennerholm, K., Philipson, J., Roupe, M., Pivodic, A., Sturedahl, A. D., Svensson, C. J., Schulman, S., & Tavoly, M. (2026). Time Trends in Cause-specific Mortality in Patients with Pulmonary Embolism Aged 50 Years and Older. Thrombosis and Haemostasis, 126(06), 595-609. https://doi.org/10.1055/a-2668-5296

Vancouver

Glise Sandblad K, Svennerholm K, Philipson J, Roupe M, Pivodic A, Sturedahl AD, et al. Time Trends in Cause-specific Mortality in Patients with Pulmonary Embolism Aged 50 Years and Older. Thrombosis and Haemostasis. 2026;126(06):595-609. doi:10.1055/a-2668-5296

BibTeX
@article{GliseSandblad2026,
  author = {Glise Sandblad, Katarina and Svennerholm, Kristina and Philipson, Jacob and Roupe, Maria and Pivodic, Aldina and Sturedahl, Andrea Dahl and Svensson, Carl Johan and Schulman, Sam and Tavoly, Mazdak},
  title = {Time Trends in Cause-specific Mortality in Patients with Pulmonary Embolism Aged 50 Years and Older},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {06},
  pages = {595--609},
  doi = {10.1055/a-2668-5296}
}
Kostenlos starten →